Affordable Access

Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.

Authors
  • Horowitz, M
  • Pasmanik-Chor, M
  • Borochowitz, Z
  • Falik-Zaccai, T
  • Heldmann, K
  • Carmi, R
  • Parvari, R
  • Beit-Or, H
  • Goldman, B
  • Peleg, L
  • Levy-Lahad, E
  • Renbaum, P
  • Legum, S
  • Shomrat, R
  • Yeger, H
  • Benbenisti, D
  • Navon, R
  • Dror, V
  • Shohat, M
  • Magal, N
  • And 2 more
Type
Published Article
Journal
Human mutation
Publication Date
Jan 01, 1998
Volume
12
Issue
4
Pages
240–244
Identifiers
PMID: 9744474
Source
Medline
License
Unknown

Abstract

Gaucher disease is the most prevalent inherited disease among Ashkenazi Jews. It is very heterogeneous due to a large number of mutations within the glucocerebrosidase gene, whose impaired activity is the cause for this disease. Aiming at determining Gaucher carrier frequency among the Ashkenazi Jewish population in Israel, 1,208 individuals were molecularly diagnosed for six mutations known to occur among Ashkenazi Jewish Gaucher patients, using the newly developed Pronto Gaucher kit. The following mutations were tested: N370S, 84GG, IVS2+1, D409H, L444P, and V394L. Molecular testing of these mutations also allows identification of the recTL allele. The results indicated that Gaucher carrier frequency is 1:17 within the tested population. The prevalence of N370S carriers is 1:17.5. This implies that approximately 1:1225 Ashkenazi Jews will be homozygous for the N370S mutation. Actually, in our study of 1,208 individuals one was found to be homozygous for the N370S mutation. The actual number of known Ashkenazi Jewish Gaucher patients with this genotype is much lower than that expected according to the frequency of the N370S mutation, suggesting a low penetrance of this mutation. Results of loading experiments in cells homozygous for the N370S mutation, as well as cells homozygous for the L444P and the D409H mutations, exemplified this phenomenon.

Report this publication

Statistics

Seen <100 times